Emerging infectious diseases · 2014
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.
Conference ProceedingsНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hendricks Katherine A, Wright Mary E, Shadomy Sean V, Bradley John S, Morrow Meredith G, Pavia Andy T, Rubinstein Ethan, Holty Jon-Erik C, Messonnier Nancy E, Smith Theresa L, Pesik Nicki, Treadwell Tracee A, Bower William A, Workgroup on Anthrax Clinical Guidelines
Аннотация
The Centers for Disease Control and Prevention convened panels of anthrax experts to review and update guidelines for anthrax postexposure prophylaxis and treatment. The panels included civilian and military anthrax experts and clinicians with experience treating anthrax patients. Specialties represented included internal medicine, pediatrics, obstetrics, infectious disease, emergency medicine, critical care, pulmonology, hematology, and nephrology. Panelists discussed recent patients with systemic anthrax; reviews of published, unpublished, and proprietary data regarding antimicrobial drugs and anthrax antitoxins; and critical care measures of potential benefit to patients with anthrax. This article updates antimicrobial postexposure prophylaxis and antimicrobial and antitoxin treatment options and describes potentially beneficial critical care measures for persons with anthrax, including clinical procedures for infected nonpregnant adults. Changes from previous guidelines include an expanded discussion of critical care and clinical procedures and additional antimicrobial choices, including preferred antimicrobial drug treatment for possible anthrax meningitis.
Предметные рубрики MeSH
AdultAnthraxAnthrax VaccinesAnti-Bacterial AgentsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntitoxinsBacillus anthracisBioterrorismCenters for Disease Control and Prevention, U.S.Clinical CompetenceCritical CareDisease ManagementHumansImmunoglobulins, IntravenousPractice Guidelines as TopicUnited States